CLRB cellectar.com: שווי החברה בספרים
The current share price of Cellectar Biosciences (CLRB) displayed on the GURU.Markets chart is 0.03. Cellectar Biosciences generates revenue by supplying radiopharmaceuticals to specialized medical centers and oncology clinics. The business's technological advantage is based on its proprietary PDC system, which minimizes side effects through targeted delivery. The expected orphan drug status will allow the brand to exercise pricing power when dealing with insurance organizations.
פילוחי מדדים מקיפים ואנליטיקה עבור Cellectar Biosciences, Inc. (CLRB)
Book value reflects the net value of equity, serving as a fundamental anchor that allows investors to filter out speculative noise from the real value of assets. By analyzing book value, an investor assesses the stability of the base of Cellectar Biosciences (CLRB), whose value is underpinned by a unique PDC platform for targeted isotope delivery, providing significant pricing power within the oncology segment.